参考文献/References:
[1] Guazzi M, Bandera F, Ozemek C, . Cardiopulmonary exercise testing: what is its value[J]. J Am Coll Cardiol,2017,70(13):1618-1636.
[2] Guazzi M, Arena R, Halle M, et al. 2016 focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations[J]. Circulation,2016,133(24): e694-711.
[3] Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Circulation,2017,135(25): e1159-e1195.
[4] van Le D, Jensen GV, Carstensen S, et al. Cardiopulmonary exercise testing in patients with asymptomatic or equivocal symptomatic aortic stenosis: feasibility, reproducibility, safety and information obtained on exercise physiology[J]. Cardiology,2016,133(3): 147-156.
[5] Domanski O, Richardson M, Coisne A, et al. Cardiopulmonary exercise testing is a better outcome predictor than exercise echocardiography in asymptomatic aortic stenosis[J]. Int J Cardiol,2017,227: 908-914.
[6] Levy F, Fayad N, Jeu A, et al. The value of cardiopulmonary exercise testing in individuals with apparently asymptomatic severe aortic stenosis: a pilot study[J]. Arch Cardiovasc Dis,2014,107(10): 519-528.
[7] Dominguez-Rodriguez A, Abreu-Gonzalez P, Mendez-Vargas C, et al. Ventilatory efficiency predicts adverse cardiovascular events in asymptomatic patients with severe aortic stenosis and preserved ejection fraction[J]. Int J Cardiol,2014,177(3): 1116-1118.
[8] Broch K, Urheim S, Massey R, et al. Exercise capacity and peak oxygen consumption in asymptomatic patients with chronic aortic regurgitation[J]. Int J Cardiol,2016,223:688-692.
[9] Hedman K, Tamás ?, Nylander E. Decreased aerobic capacity 4 years after aortic valve replacement in male patients operated upon for chronic aortic regurgitation[J]. Clin Physiol Funct Imaging,2012,32(3):167-171.
[10] Omedè P, Bucca C, Rolla G, et al. Cardiopulmonary exercise testing and exhaled nitric oxide in the assessment of patients with mitral stenosis[J]. Minerva Cardioangiol,2004,52(1):29-35.
[11] Laufer-Perl M, Gura Y, Shimiaie J, et al. Mechanisms of effort intolerance in patients with rheumatic mitral stenosis: combined echocardiography and cardiopulmonary stress?protocol[J]. JACC Cardiovasc Imaging,2017,10(6): 622-633.
[12] Dayi SU, Akbulut T, Hobiko?lu G, et al.Evaluation of success of mitral valvuloplasty in the early period with cardiopulmonary exercise test[J]. Anadolu Kardiyol Derg, 2002,2(2):108-112, AXVI.
[13] Suzuki K, Izumo M, Yoneyama K, et al. Influence of exercise-induced pulmonary hypertension on exercise capacity in asymptomatic degenerative mitral regurgitation[J]. J Cardiol,2015,66(3): 246-252.
[14] Bandera F, Generati G, Pellegrino M, et al. Mitral regurgitation in heart failure: insights from CPET combined with exercise echocardiography[J]. Eur Heart J Cardiovasc Imaging,2017,18(3): 296-303.
[15] Togna DJ, Abizaid AA, Meneghelo RS, et al. Effect of mitral valve repair on cardiopulmonary exercise testing variables in patients with chronic mitral regurgitation[J]. Arq Bras Cardiol,2013,100(4): 368-375.
[16] Lee SP, Kim YJ, Lee JM, et al. Association of heart rhythm with exercise capacity after operation for chronic mitral regurgitation[J]. Ann Thorac Surg,2012,93(6):1888-1895.
[17] de Meester P, Buys R, van de Bruaene A, et al. Functional and haemodynamic assessment of mild-to-moderate pulmonary valve stenosis at rest and during exercise[J]. Heart,2014,100(17): 1354-1359.
[18] Müller J, Engelhardt A, Fratz S, et al. Improved exercise performance and quality of life after percutaneous pulmonary valve implantation[J]. Int J Cardiol,2014,173(3): 388-392.
[19] Luijnenburg SE, Mekic S, van den Berg J, et al. Ventricular response to dobutamine stress relates to the change in peak oxygen uptake during the 5-year follow-up in young patients with repaired tetralogy of Fallot[J]. Eur Heart J Cardiovasc Imaging,2014,15(2): 189-194.
[20] Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the society for cardiovascular magnetic resonance[J]. J Am Soc Echocardiogr,2017,30(4): 303-371.
[21] Meierhofer C, Tavakkoli T, Kühn A, et al. Importance of non-invasive right and left ventricular?variables on exercise capacity in patients with tetralogy of fallot hemodynamics[J]. Pediatr Cardiol,2017,38(8):1569-1574.
[22] Dallaire F, Wald RM, Marelli A. The role of cardiopulmonary exercise testing for decision making in patients with repaired tetralogy of fallot[J]. Pediatr Cardiol,2017,38(6):1097-1105.
[23] Legendre A, Richard R, Pontnau F, et al. Usefulness of maximal oxygen pulse in timing of pulmonary valve replacement in patients with isolated pulmonary regurgitation[J]. Cardiol Young, 2016,26(7):1310-1318.
[24] Ho JG, Schamberger MS, Hurwitz RA, et al. The effects of pulmonary valve replacement for severe pulmonary regurgitation on exercise capacity and cardiac function[J]. Pediatr Cardiol,2015,36(6):1194-1203.
[25] Nakade T, Adachi H, Murata M,et al. Characteristics of patients with a relatively greater minimum VE/VCO2 against peak VO2% and impaired exercise tolerance[J]. Eur J Appl Physiol,2018,118(8):1547-1553.
[26] Müller J, Kühn A, Vogt M, et al. Improvements in exercise performance after surgery for Ebstein anomaly[J]. J Thorac Cardiovasc Surg,2011,141(5): 1192-1195.
[27] Ibrahim M, Tsang VT, Caruana M, et al. Cone reconstruction for Ebstein’s anomaly: patient outcomes, biventricular function, and cardiopulmonary exercise capacity[J]. J Thorac Cardiovasc Surg,2015,149(4): 1144-1150.
相似文献/References:
[1]蒋昭隆刘剑雄.心肺运动试验在冠心病运用现状[J].心血管病学进展,2019,(9):1290.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.027]
JIANG Zhaolong,LIU Jianxiong.Current Status of Cardiopulmonary Exercise Test in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(6):1290.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.027]
[2]张毅 罗勤 赵智慧 赵青 柳志红.心肺运动试验应用于系统性硬化病相关肺动脉高压筛查的研究进展[J].心血管病学进展,2021,(7):577.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.001]
ZHANG Yi,LUO Qin,ZHAO Zhihui,et al.Cardiopulmonary Exercise Test for Screening of Systemic Sclerosis-Associated Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2021,(6):577.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.001]
[3]谢佳 唐红 徐婷 边叶婷.心肺运动试验在右心疾病中的应用[J].心血管病学进展,2021,(10):873.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.003]
XIE JiaTANG HongXU TingBIAN Yeting.Application of Cardiopulmonary Exercise Test in Right Heart Disease[J].Advances in Cardiovascular Diseases,2021,(6):873.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.003]
[4]宋燕新 刘萍 赵威.分钟通气量和二氧化碳生成量关系对于心力衰竭患者的价值[J].心血管病学进展,2022,(5):419.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.009]
SONG Yanxin,LIU Ping,ZHAO Wei.Value of the Relationship of VE and VCO2 in Heart Failure Patients[J].Advances in Cardiovascular Diseases,2022,(6):419.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.009]
[5]应桃 吴镜.心肺运动试验在呼吸系统疾病中的应用[J].心血管病学进展,2023,(4):365.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.017]
YING Tao,WU Jing.Application of Cardiopulmonary exercise testing in respiratory disease[J].Advances in Cardiovascular Diseases,2023,(6):365.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.017]
[6]蔡珍 徐英 刘思捷 艾婷婷.心肺运动试验与冠心病相关性的研究进展[J].心血管病学进展,2024,(6):502.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.006]
CAI Zhen,XU Ying,LIU Sijie,et al.Cardiopulmonary Exercise Test and Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2024,(6):502.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.006]
[7]何璐 吴镜.心肺运动试验对肺动脉高压的临床意义[J].心血管病学进展,2024,(6):506.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.007]
HE Lu,WU Jing.Clinical Significance of Cardiopulmonary Exercise Test for Pulmonary Hypertention[J].Advances in Cardiovascular Diseases,2024,(6):506.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.007]